Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Drappatz

Showing results (51-60 of 130) with videos related to

Pageof 13
Sort By:
Oncology Nursing Forum|March 11, 2026
The Effect of Environmental Vulnerability on Family Caregiver HealthRebecca Ho, Dianxu Ren, Zhirui Deng, et al.
Journal of Neuro-Oncology|May 1, 2012
Atypical and anaplastic meningiomas treated with bevacizumabLakshmi Nayak, Fabio M Iwamoto, Jeremy D Rudnick, et al.
Magnetic Resonance in Medicine|August 1, 2014
Short-T<sub>2</sub> imaging for quantifying concentration of sodium (<sup>23</sup> Na) of bi-exponential T<sub>2</sub> relaxationYongxian Qian, Ashok Panigrahy, Charles M Laymon, et al.
Neurosurgery|April 3, 2025
Ventricular Entry During Glioblastoma Resection is Associated With Reduced Survival and Increased Risk of Distant RecurrenceNeslihan Nisa Gecici, Ahmed Habib, Arka N Mallela, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 2, 2008
Recurrent acute promyelocytic leukemia presenting as a sacral nerve root massSantosh Kesari, Jan Drappatz, Serra Akar, et al.
Neuro-Oncology|April 1, 2009
Role of a second chemotherapy in recurrent malignant glioma patients who progress on bevacizumabEudocia C Quant, Andrew D Norden, Jan Drappatz, et al.
Investigational New Drugs|November 13, 2014
Phase 2 study of CT-322, a targeted biologic inhibitor of VEGFR-2 based on a domain of human fibronectin, in recurrent glioblastomaDavid Schiff, Santosh Kesari, John de Groot, et al.
Leukemia & Lymphoma|June 5, 2012
Multicenter phase II study of rituximab and temozolomide in recurrent primary central nervous system lymphomaLakshmi Nayak, Lauren E Abrey, Jan Drappatz, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 16, 2021
The effects of SmartCare<sup>©</sup> on neuro-oncology family caregivers' distress: a randomized controlled trialFlorien W Boele, Jason M Weimer, Anna L Marsland, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 23, 2022
Correction to: The effects of SmartCare© on neuro‑oncology family caregivers' distress: a randomized controlled trialFlorien W Boele, Jason M Weimer, Anna L Marsland, et al.
Pageof 13

Showing results (51-60 of 130) with videos related to

Sort By:
Pageof 13
Oncology Nursing Forum|March 11, 2026
The Effect of Environmental Vulnerability on Family Caregiver HealthRebecca Ho, Dianxu Ren, Zhirui Deng, et al.
Journal of Neuro-Oncology|May 1, 2012
Atypical and anaplastic meningiomas treated with bevacizumabLakshmi Nayak, Fabio M Iwamoto, Jeremy D Rudnick, et al.
Magnetic Resonance in Medicine|August 1, 2014
Short-T<sub>2</sub> imaging for quantifying concentration of sodium (<sup>23</sup> Na) of bi-exponential T<sub>2</sub> relaxationYongxian Qian, Ashok Panigrahy, Charles M Laymon, et al.
Neurosurgery|April 3, 2025
Ventricular Entry During Glioblastoma Resection is Associated With Reduced Survival and Increased Risk of Distant RecurrenceNeslihan Nisa Gecici, Ahmed Habib, Arka N Mallela, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 2, 2008
Recurrent acute promyelocytic leukemia presenting as a sacral nerve root massSantosh Kesari, Jan Drappatz, Serra Akar, et al.
Neuro-Oncology|April 1, 2009
Role of a second chemotherapy in recurrent malignant glioma patients who progress on bevacizumabEudocia C Quant, Andrew D Norden, Jan Drappatz, et al.
Investigational New Drugs|November 13, 2014
Phase 2 study of CT-322, a targeted biologic inhibitor of VEGFR-2 based on a domain of human fibronectin, in recurrent glioblastomaDavid Schiff, Santosh Kesari, John de Groot, et al.
Leukemia & Lymphoma|June 5, 2012
Multicenter phase II study of rituximab and temozolomide in recurrent primary central nervous system lymphomaLakshmi Nayak, Lauren E Abrey, Jan Drappatz, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 16, 2021
The effects of SmartCare<sup>©</sup> on neuro-oncology family caregivers' distress: a randomized controlled trialFlorien W Boele, Jason M Weimer, Anna L Marsland, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 23, 2022
Correction to: The effects of SmartCare© on neuro‑oncology family caregivers' distress: a randomized controlled trialFlorien W Boele, Jason M Weimer, Anna L Marsland, et al.
Pageof 13